Web NewDrugInformation.com

Aktob Drug - Aktob The trade name of the product as shown on the labeling. Dosage - SOLUTION/DROPS; OPHTHALMIC The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Tobramycin Multiple ingredients are in alphabetical order. Strength - 0.3% The potency of the active ingredient(s), Tobramycin. May repeat for multiple part products. Applicant - AKORN The firm name holding legal responsibility for Aktob. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 064096 The FDA assigned number to Aktob. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Aktob. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AT The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Jan 31, 1996 The date Aktob was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Aktob. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Aktob is in. Format is RX, OTC, DISCN. Applicant Full Name - Akorn Inc The full name of the firm holding legal responsibility for the new application of Aktob. Aktob Tizanidine Hcl Eq 2mg Base Tablet; Oral Tizanidine Hcl Eq 4mg Base Tablet; Oral Zanaflex Eq 2mg Base Tablet; Oral Zanaflex Eq 4mg Base Tablet; Oral Tobrex 0.3% Ointment; Ophthalmic Aktob 0.3% Solution/drops; Ophthalmic Tizanidine Hcl Eq 2mg Base Tablet; Oral Tizanidine Hcl Eq 4mg Base Tablet; Oral Tizanidine Hcl Eq 2mg Base Tablet; Oral Tizanidine Hcl Eq 4mg Base Tablet; Oral NewDrugInformation